Position in NVS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,429
-$37,381 QoQ
Shares Held
29
-93.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,429 | 29 | Shares | Sole | 2026-05-13 | |
| 2021-12-31 | $41,810 | 478 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $39,090 | 478 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $43,612 | 478 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $94,625 | 1,107 | Shares | Other | 2021-05-18 | |
| 2020-12-31 | $114,071 | 1,208 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $63,741 | 733 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $105,506 | 1,208 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $102,320 | 1,241 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||